Christopher Francklyn,Karen M. Lounsbury,Jason Botten
申请号：
US14416365
公开号：
US10125358B2
申请日:
2013.07.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention includes, in part, methods and compounds for treating diseases and conditions characterized by reduced threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is reduced as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by reduced TARS activity.
